select trial semaglutide cardiovascular outcomes non-diabetic 2023 Long-term kidney of in obesity and disease in the SELECT Trial

Bydureon BCise is approved for blood sugar control in adults and children ages 10 and older with type 2 diabetes

Stop using Wegovy at least 2 months before a planned pregnancy

Retatrutide is a synthetic peptide referenced in GIP / GLP-1 / glucagon receptor research literature

In TRIUMPH-3, retatrutide meaningfully reduced certain cardiovascular risk factors, with the highest dose delivering average reductions of 37.0% in triglycerides, 16.5% in non-HDL cholesterol, 9.3 mmHg in systolic blood pressure, 7.5 in (19.0 cm) in waist circumference, and 51.2% in high-sensitivity C-reactive protein (hsCRP)

Prices can vary depending on several key factors, and knowing what to expect can help you make a confident, informed decision

[00:02:52] Dr